Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") , a clinical-stage biotechnology company leveraging its proprietary DiffuSpheretm technology designed to optimize drug delivery for ...

BioAtla (BCAB) announced preclinical poster presentations at the upcoming 2025 American Association for Cancer Research to be held at the ...

The abstracts will be available on the ASCO® website on May 22, 2025 at 5:00 p.m. ET. The full presentation will be available on the Merus website at the start of the session.

Abstracts for oral and poster presentations are now being accepted for the 2025 Western Regional Meeting. The meeting will take place October 25–28 at the Signia by Hilton Hotel in San Jose, ...

The Scientific Committee of the International Methane Measurement (IMM) event is pleased to call for papers for IMM 2025, ...

People globally celebrate Earth Day on April 22, recognizing the urgent need to help our planet. What began in 1970 as a grassroots environmental movement in the United States has since grown into the ...

Vice President JD Vance sharply criticizes the Left for demanding the return of deported illegal alien Kilmar Armando Abrego ...

MOMA Therapeutics, a clinical-stage biopharmaceutical company discovering and developing a new generation of precision therapeutics, today announced three poster presentations at the 2025 American ...

Abstracts are now being accepted for the 2025 Southeastern/Southwestern Joint Regional Meeting (SERMACS/SWRM) of the American Chemical Society. The meeting will take place Oct. 26–29 at the DoubleTree ...

The design is distinct in a world full of “floating head” movie posters (and a far cry from the Fantastic Four’s other, more ...

Details of the accepted abstracts are as follows: Title: Initial results from a first in human phase 1 study of KVA12123, an anti-VISTA antibody, alone and in combination with pembrolizumab in ...